Cargando…
Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma
Cholangiocarcinoma (CCC) is the second most primary liver cancer with an aggressive biological behavior, and its incidence increases steadily. An aberrant up-regulation of the sonic hedgehog signaling pathway has been reported in a variety of hepatic diseases including hepatic inflammation, fibrosis...
Autores principales: | Cho, Kyungjoo, Moon, Hyuk, Seo, Sang Hyun, Ro, Simon Weonsang, Kim, Beom Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707521/ https://www.ncbi.nlm.nih.gov/pubmed/34948011 http://dx.doi.org/10.3390/ijms222413214 |
Ejemplares similares
-
Knockdown of Atg7 suppresses Tumorigenesis in a murine model of liver cancer
por: Cho, Kyung Joo, et al.
Publicado: (2021) -
Genetically Engineered Mouse Models for Liver Cancer
por: Cho, Kyungjoo, et al.
Publicado: (2019) -
High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019) -
Dysregulation of sonic hedgehog signaling causes hearing loss in ciliopathy mouse models
por: Moon, Kyeong-Hye, et al.
Publicado: (2020) -
Sonic Hedgehog in SCLC
por: Laukkanen, Mikko O., et al.
Publicado: (2015)